{"nct_id":"NCT03234907","title":"Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.","status":"COMPLETED","status_verified_date":"2023-02","start_date":"2017-08-03","start_date_type":"ACTUAL","primary_completion_date":"2020-08-14","primary_completion_date_type":"ACTUAL","completion_date":"2020-08-14","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}